These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12832673)

  • 1. Time course of recovery of health status following an infective exacerbation of chronic bronchitis.
    Spencer S; Jones PW;
    Thorax; 2003 Jul; 58(7):589-93. PubMed ID: 12832673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.
    Wilson R; Schentag JJ; Ball P; Mandell L;
    Clin Ther; 2002 Apr; 24(4):639-52. PubMed ID: 12017408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of gemifloxacin: results from the GLOBE study.
    Halpern MT; Palmer CS; Zodet M; Kirsch J
    Am J Health Syst Pharm; 2002 Jul; 59(14):1357-65. PubMed ID: 12132563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind study comparing 5 days oral gemifloxacin with 7 days oral levofloxacin in patients with acute exacerbation of chronic bronchitis.
    Sethi S; Fogarty C; Fulambarker A
    Respir Med; 2004 Aug; 98(8):697-707. PubMed ID: 15303633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study group.
    File T; Schlemmer B; Garau J; Lode H; Lynch S; Young C
    J Chemother; 2000 Aug; 12(4):314-25. PubMed ID: 10949981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis.
    Wilson R; Langan C; Ball P; Bateman K; Pypstra R;
    Respir Med; 2003 Mar; 97(3):242-9. PubMed ID: 12645831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of gemifloxacin in acute exacerbations of chronic bronchitis: a randomised, double-blind comparison with trovafloxacin.
    Ball P; Wilson R; Mandell L; Brown J; Henkel T;
    J Chemother; 2001 Jun; 13(3):288-98. PubMed ID: 11450888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections.
    Ball P; File TM; Twynholm M; Henkel T
    Int J Antimicrob Agents; 2001 Jul; 18(1):19-27. PubMed ID: 11463522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S; DeAbate CA; Haverstock D; Aneiro L; Church D
    Respir Med; 2000 Jan; 94(1):18-27. PubMed ID: 10714475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Hosie J; Quinn P; Smits P; Sides G
    J Antimicrob Chemother; 1995 Jul; 36(1):173-83. PubMed ID: 8537264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.
    Grossman R; Mukherjee J; Vaughan D; Eastwood C; Cook R; LaForge J; Lampron N
    Chest; 1998 Jan; 113(1):131-41. PubMed ID: 9440580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis.
    Jivcu C; Gotfried M
    Int J Chron Obstruct Pulmon Dis; 2009; 4():291-300. PubMed ID: 19684863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis.
    Gotfried MH; DeAbate CA; Fogarty C; Mathew CP; Sokol WN
    Clin Ther; 2001 Jan; 23(1):97-107. PubMed ID: 11219483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-life treatment of acute exacerbations of chronic bronchitis with moxifloxacin or macrolides: a comparative post-marketing surveillance study in general practice.
    Schaberg T; Möller M; File T; Stauch K; Landen H
    Clin Drug Investig; 2006; 26(12):733-44. PubMed ID: 17274680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemifloxacin for the treatment of community-acquired pneumonia and acute exacerbation of chronic bronchitis: a meta-analysis of randomized controlled trials.
    Zhang L; Wang R; Falagas ME; Chen LA; Liu YN
    Chin Med J (Engl); 2012 Feb; 125(4):687-95. PubMed ID: 22490497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis.
    Milstone A; Patsimas J; Farzan D; Castaldo R; Singh H; Feurer I; Harnett J; Luke DR;
    Clin Ther; 2005 Jun; 27(6):926-39. PubMed ID: 16117993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspective.
    Lorenz J; Thate-Waschke IM; Mast O; Kubin R; Rychlik R; Pfeil T; Daniel D; Tillotson GS
    J Int Med Res; 2001; 29(2):74-86. PubMed ID: 11393351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of chest X-ray findings and other parameters in acute exacerbation of chronic bronchitis in Japan and the West.
    Watanabe A; Kohno S; Niki Y; Saito A
    J Infect Chemother; 2001 Mar; 7(1):37-44. PubMed ID: 11406755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis.
    Grassi C; Salvatori E; Rosignoli MT; Dionisio P;
    Respiration; 2002; 69(3):217-22. PubMed ID: 12097764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.